Startseite Association of anthropometric measures and cardio-metabolic risk factors in normal-weight children and adolescents: the CASPIAN-V study
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Association of anthropometric measures and cardio-metabolic risk factors in normal-weight children and adolescents: the CASPIAN-V study

  • Zeinab Ahadi , Maryam Bahreynian , Mostafa Qorbani EMAIL logo , Ramin Heshmat , Mohammad Esmaeil Motlagh , Gita Shafiee , Armita Mahdavi Gorabi , Hasan Ziaodini , Majzoubeh Taheri , Tahereh Aminaei und Roya Kelishadi EMAIL logo
Veröffentlicht/Copyright: 8. Juni 2018

Abstract

Background:

The present study aims to explore the association of anthropometric indices and cardio-metabolic risk factors in normal-weight children and adolescents.

Methods:

This cross-sectional nationwide study was conducted in 2015 among 4200 Iranian school students aged 7–18 years. They were selected using a multi-stage cluster random sampling method. Anthropometric indices and cardio-metabolic risk factors including fasting blood glucose (FBG), lipid profile and blood pressure (BP) were measured using standard protocols.

Results:

The response rate was 91.5%. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) had a significant positive correlation with waist circumference (WC), hip circumference (HC) and body mass index (BMI) in boys and girls. HDL-C had a significant inverse correlation with WC, HC and BMI in boys. For each unit increase in WC, HC and BMI, the risk of elevated DBP significantly increased by 2%, 1% and 11%, respectively. Likewise, for each unit increase in WC, HC and BMI, the risk of elevated BP significantly raised by 2%, 1% and 10%, respectively. For each unit increase in WC, the risk of metabolic syndrome increased by 7%.

Conclusions:

Anthropometric indices are considered an easy, non-invasive tool for the prediction of cardio-metabolic risk factors in normal-weight children and adolescents.

Acknowledgments

The authors would like to thank all students who participated in this survey and their parents, the school staff, data collectors, executive team, research scientists and all relevant administrators.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Fan J, Song Y, Chen Y, Hui R, Zhang W. Combined effect of obesity and cardio-metabolic abnormality on the risk of cardiovascular disease: a meta-analysis of prospective cohort studies. Int J Cardiol 2013;168:4761–8.10.1016/j.ijcard.2013.07.230Suche in Google Scholar PubMed

2. Magnussen CG, Koskinen J, Juonala M, Chen W, Srinivasan SR, et al. A diagnosis of the metabolic syndrome in youth that resolves by adult life is associated with a normalization of high carotid intima-media thickness and type 2 diabetes mellitus risk: the Bogalusa heart and cardiovascular risk in young Finns studies. J Am Coll Cardiol 2012;60:1631–9.10.1016/j.jacc.2012.05.056Suche in Google Scholar PubMed

3. Ruderman NB, Schneider SH, Berchtold P. The “metabolically-obese,” normal-weight individual. Am J Clin Nutr 1981;34:1617–21.10.1093/ajcn/34.8.1617Suche in Google Scholar PubMed

4. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S. The metabolically obese, normal-weight individual revisited. Diabetes 1998;47:699–713.10.2337/diabetes.47.5.699Suche in Google Scholar PubMed

5. St-Onge M-P, Janssen I, Heymsfield SB. Metabolic syndrome in normal-weight Americans new definition of the metabolically obese, normal-weight individual. Diabetes Care 2004;27:2222–8.10.2337/diacare.27.9.2222Suche in Google Scholar PubMed

6. Zavaroni I, Bonora E, Pagliara M, Dall’Aglio E, Luchetti L, et al. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 1989;320:702–6.10.1056/NEJM198903163201105Suche in Google Scholar PubMed

7. Karelis AD, Faraj M, Bastard J-P, St-Pierre DH, Brochu M, et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 2005;90:4145–50.10.1210/jc.2005-0482Suche in Google Scholar PubMed

8. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, et al. The obese without cardio-metabolic risk factor clustering and the normal weight with cardio-metabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch Intern Med 2008;168:1617–24.10.1001/archinte.168.15.1617Suche in Google Scholar PubMed

9. Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 2008;168:1609–16.10.1001/archinte.168.15.1609Suche in Google Scholar PubMed

10. Brochu M, Tchernof A, Dionne IJ, Sites CK, Eltabbakh GH, et al. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab 2001;86:1020–5.10.1210/jc.86.3.1020Suche in Google Scholar

11. Kelishadi R, Cook SR, Motlagh ME, Gouya MM, Ardalan G, et al. Metabolically obese normal weight and phenotypically obese metabolically normal youths: the CASPIAN Study. J Am Diet Assoc 2008;108:82–90.10.1016/j.jada.2007.10.013Suche in Google Scholar PubMed

12. Kip KE, Marroquin OC, Kelley DE, Johnson BD, Kelsey SF, et al. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women a report from the Women’s Ischemia Syndrome Evaluation (WISE) study. Circulation 2004;109:706–13.10.1016/j.accreview.2004.04.053Suche in Google Scholar

13. St-Pierre AC, Cantin B, Mauriège P, Bergeron J, Dagenais GR, et al. Insulin resistance syndrome, body mass index and the risk of ischemic heart disease. Can Med Assoc J 2005;172:1301–5.10.1503/cmaj.1040834Suche in Google Scholar PubMed PubMed Central

14. Katzmarzyk PT, Church TS, Janssen I, Ross R, Blair SN. Metabolic syndrome, obesity, and mortality impact of cardiorespiratory fitness. Diabetes Care 2005;28:391–7.10.2337/diacare.28.2.391Suche in Google Scholar PubMed

15. Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006;91:2906–12.10.1210/jc.2006-0594Suche in Google Scholar PubMed

16. Kuk JL, Ardern CI. Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care 2009;32:2297–9.10.2337/dc09-0574Suche in Google Scholar PubMed PubMed Central

17. Ärnlöv J, Ingelsson E, Sundström J, Lind L. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 2010;121:230–6.10.1161/CIRCULATIONAHA.109.887521Suche in Google Scholar PubMed

18. Flint AJ, Hu FB, Glynn RJ, Caspard H, Manson JE, et al. Excess weight and the risk of incident coronary heart disease among men and women. Obesity 2010;18:377–83.10.1038/oby.2009.223Suche in Google Scholar PubMed PubMed Central

19. Ogorodnikova AD, Kim M, McGinn AP, Muntner P, Khan U, et al. Incident cardiovascular disease events in metabolically benign obese individuals. Obesity 2012;20:651–9.10.1038/oby.2011.243Suche in Google Scholar PubMed PubMed Central

20. Ortega FB, Lee D-C, Katzmarzyk PT, Ruiz JR, Sui X, et al. The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. Eur Heart J 2013;34:389–97.10.1093/eurheartj/ehs174Suche in Google Scholar PubMed PubMed Central

21. Savva S, Tornaritis M, Savva M, Kourides Y, Panagi A, et al. Waist circumference and waist-to-height ratio are better predictors of cardiovascular disease risk factors in children than body mass index. Int J Obes 2000;24:1453.10.1038/sj.ijo.0801401Suche in Google Scholar

22. Hara M, Saitou E, Iwata F, Okada T, Harada K. Waist-to-height ratio is the best predictor of cardiovascular disease risk factors in Japanese schoolchildren. J Atheroscler Thromb 2002;9:127–32.10.5551/jat.9.127Suche in Google Scholar

23. Kahn HS, Imperatore G, Cheng YJ. A population-based comparison of BMI percentiles and waist-to-height ratio for identifying cardiovascular risk in youth. J Pediatr 2005;146:482–8.10.1016/j.jpeds.2004.12.028Suche in Google Scholar

24. Freedman DS, Kahn HS, Mei Z, Grummer-Strawn LM, Dietz WH, et al. Relation of body mass index and waist-to-height ratio to cardiovascular disease risk factors in children and adolescents: the Bogalusa Heart Study. Am J Clin Nutr 2007;86:33–40.10.1093/ajcn/86.1.33Suche in Google Scholar

25. Adegboye A, Andersen LB, Froberg K, Sardinha L, Heitmann B. Linking definition of childhood and adolescent obesity to current health outcomes. Int J Pediatr Obes 2010;5:130–42.10.3109/17477160903111730Suche in Google Scholar

26. Kahn HS, Jago R, Foster GD, McMurray RG, Buse JB, et al. Cardio-metabolic risk assessments by body mass index z-score or waist-to-height ratio in a multiethnic sample of sixth-graders. J Obes 2014;2014. Doi: 10.1155/2014/421658.10.1155/2014/421658Suche in Google Scholar

27. Motlagh ME, Ziaodini H, Qorbani M, Taheri M, Aminaei T, et al. Methodology and early findings of the fifth survey of childhood and adolescence surveillance and prevention of adult noncommunicable disease: the CASPIAN-V study. Int J Prev Med 2017;8:4. Doi: 10.4103/2008-7802.198915.10.4103/2008-7802.198915Suche in Google Scholar

28. Kelishadi R, Motlagh ME, Roomizadeh P, Abtahi S-H, Qorbani M, et al. First report on path analysis for cardio-metabolic components in a nationally representative sample of pediatric population in the Middle East and North Africa (MENA): the CASPIAN-III Study. Ann Nutr Metab 2013;62:257–65.10.1159/000346489Suche in Google Scholar

29. World Health Organization. Expert committee on physical status. Physical status: the use and interpretation of anthropometry. Geneva: WHO, 1995.Suche in Google Scholar

30. Caro DH, Cortés D. Measuring family socioeconomic status: an illustration using data from PIRLS 2006. IERI Monograph Series Issues and Methodologies in Large-Scale Assessments. 2012;5:9–33.Suche in Google Scholar

31. Zimmet P, Alberti G, Kaufman F, Tajima N, Silink M, et al. The metabolic syndrome in children and adolescents. Lancet (London, England) 2007;369:2059–61.10.1016/S0140-6736(07)60958-1Suche in Google Scholar

32. Balagopal PB, de Ferranti SD, Cook S, Daniels SR, Gidding SS, et al. Nontraditional risk factors and biomarkers for cardiovascular disease: mechanistic, research, and clinical considerations for youth: a scientific statement from the American Heart Association. Circulation 2011;123:2749–69.10.1161/CIR.0b013e31821c7c64Suche in Google Scholar PubMed

33. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143–421.10.1161/circ.106.25.3143Suche in Google Scholar

34. Knowles K, Paiva L, Sanchez S, Revilla L, Lopez T, et al. Waist circumference, body mass index, and other measures of adiposity in predicting cardiovascular disease risk factors among Peruvian adults. Int J Hypertens 2011;2011:931402.10.4061/2011/931402Suche in Google Scholar

35. Li C, Ford ES, Mokdad AH, Cook S. Recent trends in waist circumference and waist-height ratio among US children and adolescents. Pediatrics 2006;118:e1390–8.10.1542/peds.2006-1062Suche in Google Scholar

36. Wicklow B, Becker A, Chateau D, Palmer K, Kozyrskij A, et al. Comparison of anthropometric measurements in children to predict metabolic syndrome in adolescence: analysis of prospective cohort data. Int J Obes 2015;39:1070–8.10.1038/ijo.2015.55Suche in Google Scholar

37. Sardinha LB, Santos DA, Silva AM, Grontved A, Andersen LB, et al. A comparison between BMI, waist circumference, and waist-to-height ratio for identifying cardio-metabolic risk in children and adolescents. PLoS One 2016;11:e0149351.10.1371/journal.pone.0149351Suche in Google Scholar

38. Mišigoj-Duraković M, Sorić M, Duraković Z. Anthropometry in cardio-metabolic risk assessment. Arhiv za higijenu rada i toksikologiju 2014;65:19–26.10.2478/10004-1254-65-2014-2381Suche in Google Scholar

39. Garnett S, Baur L, Cowell C. Waist-to-height ratio: a simple option for determining excess central adiposity in young people. Int J Obes 2008;32:1028–30.10.1038/ijo.2008.51Suche in Google Scholar

40. Okosun IS, Liao Y, Rotimi CN, Choi S, Cooper RS. Predictive values of waist circumference for dyslipidemia, type 2 diabetes and hypertension in overweight White, Black, and Hispanic American adults. J Clin Epidemiol 2000;53:401–8.10.1016/S0895-4356(99)00217-6Suche in Google Scholar

41. Levit RD, Reynolds HR, Hochman JS. Cardiovascular disease in young women: a population at risk. Cardiol Rev 2011; 19:60–5.10.1097/CRD.0b013e31820987b5Suche in Google Scholar PubMed

42. Suadicani P, Hein HO, von Eyben FE, Gyntelberg F. Metabolic and lifestyle predictors of ischemic heart disease and all-cause mortality among normal weight, overweight, and obese men: a 16-year follow-up in the Copenhagen Male Study. Metab Syndr Relat Disord 2009;7:97–104.10.1089/met.2008.0041Suche in Google Scholar PubMed

43. Emerging Risk Factors Collaboration, Danesh J, Erqou S, Walker M, Thompson SG, et al. The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol 2007;22:839–69.10.1007/s10654-007-9165-7Suche in Google Scholar PubMed

44. Mihalache L, Graur LI, Popescu DS, Nita O, Graur M. Anthropometric parameters – predictive factors for cardio-metabolic diseases. Rev Med Chir Soc Med Nat Iasi 2012;116:794–8.Suche in Google Scholar

45. Ferrannini E, Balkau B, Coppack SW, Dekker JM, Mari A, et al. Insulin resistance, insulin response, and obesity as indicators of metabolic risk. J Clin Endocrinol Metab 2007;92:2885–92.10.1210/jc.2007-0334Suche in Google Scholar PubMed

46. Pataky Z, Makoundou V, Nilsson P, Gabriel RS, Lalic K, et al. Metabolic normality in overweight and obese subjects. Which parameters? Which risks? Int J Obes (Lond) 2011;35:1208–15.10.1038/ijo.2010.264Suche in Google Scholar PubMed

47. Friend A, Craig L, Turner S. The prevalence of metabolic syndrome in children: a systematic review of the literature. Metab Syndr Relat Disord 2013;11:71–80.10.1089/met.2012.0122Suche in Google Scholar PubMed

Received: 2018-01-13
Accepted: 2018-04-23
Published Online: 2018-06-08
Published in Print: 2018-08-28

©2018 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Original Articles
  3. Urinary bisphenol-A levels in children with type 1 diabetes mellitus
  4. The relationship between metabolic syndrome, cytokines and physical activity in obese youth with and without Prader-Willi syndrome
  5. Association of anthropometric measures and cardio-metabolic risk factors in normal-weight children and adolescents: the CASPIAN-V study
  6. The effect of obesity and insulin resistance on macular choroidal thickness in a pediatric population as assessed by enhanced depth imaging optical coherence tomography
  7. Hereditary 1,25-dihydroxyvitamin D-resistant rickets (HVDRR): clinical heterogeneity and long-term efficacious management of eight patients from four unrelated Arab families with a loss of function VDR mutation
  8. Long-term thyroid disorders in pediatric survivors of hematopoietic stem cell transplantation after chemotherapy-only conditioning
  9. Screening for autoimmune thyroiditis and celiac disease in minority children with type 1 diabetes
  10. Resistance exercise alone improves muscle strength in growth hormone deficient males in the transition phase
  11. Sequential measurements of IGF-I serum concentrations in adolescents with Laron syndrome treated with recombinant human IGF-I (rhIGF-I)
  12. Symptomatic Rathke cleft cyst in paediatric patients – clinical presentations, surgical treatment and postoperative outcomes – an analysis of 38 cases
  13. Molecular genetics of tetrahydrobiopterin deficiency in Chinese patients
  14. Single center experience of biotinidase deficiency: 259 patients and six novel mutations
  15. Next-generation sequencing as a second-tier diagnostic test for newborn screening
  16. Case Reports
  17. Thyroid storm after choking
  18. Three new Brazilian cases of 17α-hydroxylase deficiency: clinical, molecular, hormonal, and treatment features
  19. Diazoxide toxicity in a child with persistent hyperinsulinemic hypoglycemia of infancy: mixed hyperglycemic hyperosmolar coma and ketoacidosis
  20. Refractory hypoglycemia in a pediatric patient with desmoplastic small round cell tumor
Heruntergeladen am 17.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2018-0018/html
Button zum nach oben scrollen